Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Pseudotumor cerebri is caused by:

Vitamin A overdose. **Explanation:** **Pseudotumor cerebri**, also known as **Idiopathic Intracranial Hypertension (IIH)**, is a clinical syndrome characterized by increased intracranial pressure (ICP) in the absence of a space-occupying lesion or hydrocephalus. **Why Vitamin A is the correct answer:** Hypervitaminosis A (both acute and chronic) is a well-documented cause of secondary intracranial hypertension. Excessive intake of Vitamin A or its derivatives (like **Isotretinoin** used in acne treatment) impairs the resorption of cerebrospinal fluid (CSF) at the arachnoid villi, leading to elevated ICP. Patients typically present with headaches, papilledema, and occasionally CN VI (abducens) nerve palsy. **Analysis of Incorrect Options:** * **A. Acetazolamide:** This is actually the **treatment of choice** for IIH. As a carbonic anhydrase inhibitor, it reduces CSF production, thereby lowering intracranial pressure. * **C. Methotrexate:** While methotrexate has significant toxicities (bone marrow suppression, hepatotoxicity, mucositis), it is not classically associated with pseudotumor cerebri. * **D. Excessive iron therapy:** Iron overload (hemochromatosis or acute poisoning) primarily affects the liver, heart, and endocrine organs; it does not cause increased intracranial pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Drugs causing Pseudotumor Cerebri (P-A-T-S):** **P**henytoin/Oral Contraceptives, **A**miodarone, **T**etracyclines (Doxycycline/Minocycline), **S**teroids (withdrawal) and Vitamin **A**. * **Classic Patient Profile:** Obese female of childbearing age. * **Diagnosis:** Lumbar puncture shows **elevated opening pressure** (>250 mmH2O) with normal CSF composition. * **Complication:** The most serious risk is permanent vision loss due to optic nerve atrophy.

Q: Which of the following is a calcineurin inhibitor?

Cyclosporine. **Explanation:** **Cyclosporine** is the correct answer because it belongs to the class of **Calcineurin Inhibitors (CNIs)**. Its mechanism involves binding to an intracellular protein called **Cyclophilin**. This complex then inhibits Calcineurin, a phosphatase responsible for dephosphorylating the "Nuclear Factor of Activated T-cells" (NFAT). Without dephosphorylation, NFAT cannot enter the nucleus to promote the transcription of **Interleukin-2 (IL-2)**, thereby preventing T-cell activation and proliferation. **Analysis of Incorrect Options:** * **Cyclophosphamide (A):** An alkylating agent that cross-links DNA. It is a cytotoxic drug used in chemotherapy and for severe autoimmune diseases, but it does not target calcineurin. * **Etanercept (C):** A biological DMARD that acts as a **TNF-alpha inhibitor**. It is a fusion protein that mimics the TNF receptor, "mopping up" circulating TNF-alpha. * **Sirolimus (D):** Also known as Rapamycin, it binds to FKBP-12 (like Tacrolimus) but inhibits **mTOR** (mammalian Target of Rapamycin) rather than calcineurin. It blocks the *response* to IL-2 rather than its *production*. **High-Yield Clinical Pearls for NEET-PG:** * **Calcineurin Inhibitors:** Include **Cyclosporine** and **Tacrolimus** (Tacrolimus binds to FKBP-12). * **Side Effects of Cyclosporine:** Nephrotoxicity (most common), Gingival Hyperplasia, Hirsutism, and Hypertension. * **Comparison:** Unlike Cyclosporine, **Tacrolimus** is more potent and does *not* cause gingival hyperplasia or hirsutism but has a higher risk of post-transplant diabetes. * **Monitoring:** Both CNIs require Therapeutic Drug Monitoring (TDM) due to their narrow therapeutic index.

Q: Which of the following conditions increases the risk of digoxin toxicity?

Administration of quinidine. **Explanation:** Digoxin has a narrow therapeutic index, making it prone to toxicity. The correct answer is **Administration of quinidine** due to two primary pharmacokinetic interactions: 1. **Displacement:** Quinidine displaces digoxin from tissue binding sites (skeletal muscle). 2. **Reduced Excretion:** It inhibits P-glycoprotein (P-gp) in the renal tubules, significantly reducing the renal clearance of digoxin. This can lead to a doubling of plasma digoxin levels. **Analysis of Incorrect Options:** * **B. Hyperkalemia:** Potassium and digoxin compete for the same binding site on the **Na+/K+ ATPase pump**. Therefore, *hypokalemia* (low potassium) increases digoxin binding and toxicity, whereas hyperkalemia actually antagonizes digoxin’s effects. * **C. Hypermagnesemia:** *Hypomagnesemia* is a known risk factor for digoxin toxicity. Magnesium acts as a cofactor for the Na+/K+ ATPase pump; its deficiency sensitizes the myocardium to arrhythmias. * **D. Hypocalcemia:** Digoxin works by increasing intracellular calcium. *Hypercalcemia* (high calcium) synergizes with digoxin, increasing the risk of "stone heart" and arrhythmias. Hypocalcemia generally reduces this risk. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Toxicity Factors:** "Hypo K, Hypo Mg, Hyper Ca" (Low K, Low Mg, High Ca). * **Drug Interactions:** Apart from quinidine, **Verapamil, Amiodarone, and Spironolactone** also increase digoxin levels by inhibiting P-gp. * **Early Sign of Toxicity:** Gastrointestinal symptoms (anorexia, nausea, vomiting). * **Characteristic Sign:** Xanthopsia (yellowish-green vision). * **ECG Finding:** "Reverse Tick" or "Sagging" ST-segment depression. * **Antidote:** Digoxin-specific antibody fragments (DigiFab).

Q: What is the antidote for methanol poisoning?

Fomepizole. Methanol poisoning is a medical emergency characterized by metabolic acidosis and retinal damage. The toxicity is not caused by methanol itself, but by its metabolite, **formic acid**, produced via the enzyme **alcohol dehydrogenase (ADH)** [1]. **1. Why Fomepizole is correct:** Fomepizole is a potent competitive inhibitor of **alcohol dehydrogenase**. By blocking this enzyme, it prevents the conversion of methanol into its toxic metabolites (formaldehyde and formic acid) [1]. This allows the parent methanol to be excreted harmlessly by the kidneys. It is the preferred antidote over ethanol due to its predictable pharmacokinetics and lack of CNS depression. **2. Why other options are incorrect:** * **Foscarnet:** An antiviral agent used primarily for CMV retinitis in HIV patients; it has no role in toxicology. * **Morphine:** An opioid analgesic; its use in methanol poisoning would be dangerous as it could further depress the respiratory system. * **Bupropion:** An atypical antidepressant and smoking cessation aid; it can actually lower the seizure threshold, which is counterproductive in toxic ingestions. **Clinical Pearls for NEET-PG:** * **The "M" in MUDPILES:** Methanol is a classic cause of High Anion Gap Metabolic Acidosis (HAGMA). * **Classic Presentation:** "Snowfield vision" or blurred vision due to optic papillitis. * **Alternative Antidote:** If Fomepizole is unavailable, **Ethanol** can be used as it has a higher affinity for ADH than methanol [1]. * **Adjunctive Therapy:** **Folic acid** (leucovorin) is administered to enhance the breakdown of formic acid into carbon dioxide and water. * **Definitive Treatment:** Hemodialysis is indicated in severe cases (high levels or severe acidosis).

Q: The appearance of markedly vacuolated, nucleated red cells in the marrow, anemia and reticulocytopenia are characteristic dose-dependent side effects of which drug?

Chloramphenicol. **Explanation:** **Chloramphenicol** is associated with two distinct types of bone marrow toxicity. The correct answer refers to the **dose-dependent, reversible bone marrow suppression**. This occurs because chloramphenicol inhibits mitochondrial protein synthesis in mammalian host cells (specifically the 70S ribosomes in mitochondria). Key features of this toxicity include: * **Morphology:** The hallmark finding is the appearance of **vacuolated nucleated red cell precursors** (erythroblasts) in the bone marrow. * **Clinical Presentation:** Anemia, reticulocytopenia, and sometimes leucopenia or thrombocytopenia. * **Nature:** It is predictable, related to high serum concentrations (>25 µg/mL), and reverses upon drug discontinuation. *Note: This is distinct from the idiosyncratic, irreversible **Aplastic Anemia**, which is rare, not dose-dependent, and often fatal.* **Why other options are incorrect:** * **Azithromycin (Macrolide):** Primarily causes GI upset and cholestatic jaundice; it does not cause marrow suppression or vacuolation. * **Clindamycin (Lincosamide):** Most notorious for causing *Clostridioides difficile*-associated pseudomembranous colitis. * **Doxycycline (Tetracycline):** Known for teeth discoloration, photosensitivity, and esophageal ulcers; it is not associated with marrow vacuolation. **High-Yield Clinical Pearls for NEET-PG:** 1. **Grey Baby Syndrome:** Occurs in neonates due to deficient **glucuronyl transferase** enzyme, leading to chloramphenicol accumulation. 2. **Mechanism of Action:** Binds to the **50S ribosomal subunit** (inhibits peptidyl transferase). 3. **Drug of Choice:** Though limited by toxicity, it remains a drug of choice for **H. influenzae meningitis** (in penicillin-allergic patients) and occasionally for **Typhoid fever** or **Rickettsial infections** in specific settings.

Q: Which of the following is NOT used for treating acute iron poisoning?

BAL. **Explanation:** Acute iron poisoning is a medical emergency often seen in children. The management focuses on preventing absorption, supportive care, and chelation therapy. **Why BAL is the correct answer:** **BAL (British Anti-Lewisite/Dimercaprol)** is contraindicated in iron poisoning. Dimercaprol forms a complex with iron that is **nephrotoxic**. It is primarily used for heavy metals like arsenic, mercury, and lead, but it must be avoided in iron and cadmium toxicity. **Analysis of other options:** * **Desferrioxamine (Option A):** This is the **specific antidote** (chelating agent) for iron poisoning. It binds to ferric iron to form ferrioxamine, which is excreted in the urine (often turning urine a "vin-rose" color). * **Magnesium hydroxide (Option C):** This is used as a local neutralizing agent. It reacts with iron in the gastrointestinal tract to form insoluble iron salts, thereby reducing systemic absorption. * **Hemodialysis (Option D):** While hemodialysis **cannot** remove iron directly (as iron is bound to transferrin or ferritin), it is used in severe cases to manage complications like metabolic acidosis and acute renal failure resulting from the toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Desferrioxamine (IV is preferred in severe cases). * **Oral Chelator:** Deferiprone or Deferasirox (used for chronic iron overload, e.g., Thalassemia). * **Gastric Lavage:** Performed with sodium bicarbonate or saline; however, **Activated Charcoal is NOT effective** as it does not bind to iron. * **Abdominal X-ray:** Iron tablets are radio-opaque and can be visualized on a plain film.

Q: In which of the following poisonings can hemodialysis be indicated?

Benzodiazepine toxicity. **Explanation:** The question asks for a condition where hemodialysis is **indicated**. However, there is a discrepancy in the provided key: **Benzodiazepine toxicity is NOT typically treated with hemodialysis**, whereas Aspirin, Methanol, and Barbiturates are classic indications. **Understanding Hemodialysis in Toxicology (The "ISTUMBLE" Mnemonic):** For a drug to be effectively removed by hemodialysis, it must have a **low molecular weight, low volume of distribution (Vd 100 mg/dL acute). Aspirin has a small Vd and is easily cleared once protein binding is saturated. 2. **Methanol:** Hemodialysis is indicated to remove both the parent alcohol and its toxic metabolite (formic acid) to prevent retinal damage and severe metabolic acidosis [1]. 3. **Barbiturates:** Long-acting barbiturates (like Phenobarbital) are effectively removed by hemodialysis/hemoperfusion due to their low Vd and renal excretion profile. 4. **Benzodiazepines (Correct Answer per your key, but clinically incorrect):** Benzodiazepines have a **very large Volume of Distribution (Vd)** and are highly lipid-soluble. Therefore, they remain in the tissues and are **not** effectively removed by hemodialysis. The specific antidote is **Flumazenil**. **High-Yield NEET-PG Pearls:** * **Mnemonic for Dialyzable drugs (BLAST-M):** **B**arbiturates (long-acting), **L**ithium, **A**lcohols (Methanol/Ethylene glycol), **S**alicylates, **T**heophylline, **M**etformin [1]. * **Non-dialyzable drugs:** Digoxin, Benzodiazepines, Opioids, and Tricyclic Antidepressants (due to high Vd). * **Urinary Alkalinization:** Used for weak acids like Salicylates and Phenobarbital to enhance renal excretion (Ion trapping).

Q: A patient with depressive disorder has taken 25 times the normal dose of amitriptyline. Which of the following is not likely to be observed in this patient?

Pinpoint pupil. Amitriptyline is a **Tricyclic Antidepressant (TCA)**. In overdose, TCAs exhibit a classic toxidrome characterized by three main mechanisms: anticholinergic effects, alpha-1 adrenergic blockade, and sodium channel blockade (quinidine-like effects). ### Why "Pinpoint Pupil" is the Correct Answer: Amitriptyline has potent **antimuscarinic (anticholinergic) properties**. In an overdose, it causes **Mydriasis (dilated pupils)** due to the blockade of muscarinic receptors in the pupillary sphincter muscle. **Pinpoint pupils (Miosis)** are characteristic of opioid overdose or organophosphate poisoning, not TCA toxicity. ### Explanation of Incorrect Options: * **Coma and shock:** TCAs are highly CNS-toxic in overdose, leading to altered mental status, seizures, and coma. Shock results from a combination of decreased myocardial contractility (sodium channel blockade) and peripheral vasodilation. * **Hot dry skin:** This is a hallmark of the **anticholinergic toxidrome** ("Hot as a hare, dry as a bone"). Inhibition of sweat glands (which are mediated by muscarinic receptors) leads to hyperthermia and anhidrosis. * **Hypotension:** This occurs due to **Alpha-1 adrenergic receptor blockade**, causing peripheral vasodilation, coupled with direct myocardial depression. ### High-Yield Clinical Pearls for NEET-PG: * **The 3 C’s of TCA Poisoning:** **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias). * **ECG Changes:** The most characteristic finding is **QRS widening** (>100ms) and a prominent R wave in lead aVR. * **Antidote:** The specific treatment for TCA-induced cardiotoxicity (QRS widening/arrhythmias) is **Intravenous Sodium Bicarbonate**. * **Contraindication:** Physostigmine is generally avoided in TCA overdose as it can worsen cardiac conduction delays and trigger seizures.

Q: All are effective treatment modalities for acetaminophen overdose, EXCEPT:

High dose vitamin E. Acetaminophen (Paracetamol) toxicity is primarily mediated by its reactive metabolite, NAPQI [1]. When glutathione stores are depleted, NAPQI causes centrilobular hepatic necrosis [3]. While Vitamin E is an antioxidant, it has no proven clinical role in the acute management of acetaminophen toxicity. It cannot conjugate NAPQI or replenish glutathione stores effectively in an emergency setting. Therefore, it is not a standard treatment modality. Analysis of other options: Gastric Lavage: This is effective if performed early (usually within 1 hour of ingestion) to prevent further absorption of the drug from the GI tract [1]. Oral Activated Charcoal: This is highly effective at adsorbing acetaminophen. It is most beneficial when administered within 1–2 hours of ingestion [1]. Cysteamine: This was one of the first antidotes used for paracetamol poisoning. Like N-acetylcysteine (NAC), it acts as a precursor to glutathione. However, it is rarely used today because it causes significant side effects (nausea, vomiting, flushing) compared to NAC. High-Yield Clinical Pearls for NEET-PG: Antidote of Choice: N-acetylcysteine (NAC) [2]. It works by replenishing glutathione stores and acting as a glutathione substitute [1]. Rumack-Matthew Nomogram: Used to predict hepatotoxicity based on plasma acetaminophen levels starting at 4 hours post-ingestion [1]. Toxic Metabolite: NAPQI (N-acetyl-p-benzoquinone imine) [1]. Toxicity Threshold: Acute ingestion of >7.5g in adults or >150mg/kg in children is considered potentially toxic.

Q: Glucose intolerance is seen with which of the following medications?

All of the above. **Explanation:** Glucose intolerance (hyperglycemia) is a common side effect of several non-diabetic medications. The correct answer is **All of the above** because each of these drugs interferes with glucose metabolism through different physiological mechanisms. 1. **Thiazide Diuretics (e.g., Chlorthalidone, Hydrochlorothiazide):** These are notorious for causing hyperglycemia. They induce **hypokalemia** (low potassium), which inhibits the release of insulin from pancreatic beta cells (as insulin secretion is a potassium-dependent process). They also decrease peripheral insulin sensitivity. 2. **Beta Blockers (e.g., Atenolol, Propranolol):** Non-selective beta-blockers inhibit $\beta_2$-receptors on pancreatic islet cells, leading to **decreased insulin secretion**. Additionally, they can mask the autonomic warning symptoms of hypoglycemia (like tachycardia and tremors), making them risky for diabetic patients. 3. **Phenytoin:** This antiepileptic drug directly **inhibits the release of insulin** from the pancreas. It is a classic cause of drug-induced hyperglycemia in patients being treated for seizures. **Clinical Pearls for NEET-PG:** * **Other drugs causing hyperglycemia:** Glucocorticoids (increase gluconeogenesis), Oral Contraceptives, Niacin, and Protease Inhibitors (HAART). * **Thiazide alternative:** In diabetic patients with hypertension, **ACE inhibitors or ARBs** are preferred as they are renoprotective and do not affect glucose levels. * **Beta-blocker exception:** Vasodilatory beta-blockers like **Carvedilol and Nebivolol** have a neutral or even beneficial effect on glycemic control compared to older agents like Atenolol.

Question 1

Pseudotumor cerebri is caused by:

Accepted Answer

Vitamin A overdose

Answer

Acetazolamide

Answer

Methotrexate overdose

Answer

Excessive iron therapy

Question 2

Which of the following is a calcineurin inhibitor?

Accepted Answer

Cyclosporine

Answer

Cyclophosphamide

Answer

Etanercept

Answer

Sirolimus

Question 3

Which of the following conditions increases the risk of digoxin toxicity?

Accepted Answer

Administration of quinidine

Answer

Hyperkalemia

Answer

Hypermagnesemia

Answer

Hypocalcemia

Question 4

What is the antidote for methanol poisoning?

Accepted Answer

Fomepizole

Answer

Foscarnet

Answer

Morphine

Answer

Bupropion

Question 5

The appearance of markedly vacuolated, nucleated red cells in the marrow, anemia and reticulocytopenia are characteristic dose-dependent side effects of which drug?

Accepted Answer

Chloramphenicol

Answer

Azithromycin

Answer

Clindamycin

Answer

Doxycycline

Question 6

Which of the following is NOT used for treating acute iron poisoning?

Accepted Answer

BAL

Answer

Desferrioxamine

Answer

Magnesium hydroxide

Answer

Hemodialysis

Question 7

In which of the following poisonings can hemodialysis be indicated?

Accepted Answer

Benzodiazepine toxicity

Answer

Aspirin toxicity

Answer

Methanol toxicity

Answer

Barbiturate toxicity

Question 8

A patient with depressive disorder has taken 25 times the normal dose of amitriptyline. Which of the following is not likely to be observed in this patient?

Accepted Answer

Pinpoint pupil

Answer

Coma and shock

Answer

Hot dry skin

Answer

Hypotension

Question 9

All are effective treatment modalities for acetaminophen overdose, EXCEPT:

Accepted Answer

High dose vitamin E

Answer

Gastric lavage

Answer

Oral activated charcoal

Answer

Cysteamine

Question 10

Glucose intolerance is seen with which of the following medications?

Accepted Answer

All of the above

Answer

Thiazide diuretics

Answer

Beta blockers

Answer

Phenytoin

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?